Objective: We aimed to investigate the mucosal activation of a broad range of genes associated with the Th17 signalling pathway in children at different stages of CD; including children with increased risk for CD, children with untreated and gluten-free diet (GFD)-treated CD.
Introduction
Celiac disease (CD) is a common autoimmune disorder which develops in genetically susceptible individuals, positive for HLA-DQ2/DQ8, as a result of intolerance to dietary gluten. CD has often been considered as a classical malabsorption state characterized by severe mucosal villous atrophy with crypt hyperplasia together with immune cell infiltration and inflammation in the small intestinal mucosa. Nowadays, also mild inflammation with partial villous atrophy is becoming a more common phenotype of CD at presentation. Individuals with elevated CD associated transglutaminase autoantibodies without villous atrophy, who are considered to have increased risk of CD and so called potential CD, are also a part of the broad spectrum of CD. Approximately one third of the subjects with potential CD developed villous atrophy and acute CD within a few years if they continued on a gluten containing diet [1] . So far the only available treatment of CD is a lifelong strict gluten-free diet (GFD), which causes clinical improvement and normalization of the villous atrophy together with improvement of the intestinal inflammation.
It is known that CD is characterized by mucosal up-regulation of the interferon (IFN)-γ pathway [2] [3] [4] . Gluten reactive T-cells have been shown to secrete IFN-, emphasizing the role of T-helper (Th)1 associated immune responses in the pathogenesis [5] . We recently reported that children with untreated CD displayed mucosal up-regulation of the IFN-γ pathway, which remained elevated even one year after GFD treatment. This suggests that activation of the Th1 response seems to be more fundamentally associated with CD, being present already in individuals with potential CD and also remaining in GFD-treated CD patients with normal villous structure [6] .
Recently elevated interleukin (IL)-17 responses were reported after exposure to wheat gliadin in acute CD but not in potential CD indicating association of up-regulated IL-17 pathway with villous atrophy [7] [8] [9] . However, T-cell clones reactive with deamidated gliadin peptide did not show IL-17 secretion [5] which suggests that activation of IL-17 may not be induced directly by dietary gluten, but rather develops at later stage of mucosal inflammation. IL-17 has been speculated to act as a counter-regulatory molecule limiting the intestinal inflammation (induced by Th1 cells) [8] . We have reported that IL-17 induced anti-apoptotic bcl-2 responses in an intestinal epithelial cell line [9] . Another regulatory factor, FOXP3, has been reported to be up-regulated also in acute CD.
In summary, the complex network of mucosal immune activation in CD is poorly understood and it seems that changing pattern of Th1/Th17/Treg activation is seen at different stages of CD.
To understand the role of IL-17 immunity in CD, we analysed the intestinal expression profile of Th17 related genes in reference children, children with transglutaminase antibody (TGA) positivity (potential CD), and in children with untreated CD and GFD-treated CD.
Methods

Study subjects
Small intestinal biopsy samples were obtained from 33 children (mean age: 6.9 years, range 1-18 years, 21 girls and 12 boys) who underwent small intestinal biopsy sampling at the Paediatric Clinic, University Hospital Linköping or at the Paediatric Clinic in Norrköping or Motala for suspicion of or confirmation of CD ( Table 1) . The study population comprises four groups: nine children with untreated CD displaying a morphological picture of CD (untreated CD); eight CD children who have followed a strict exclusion diet for one year with a normalized mucosa (GFD treated CD); eight children with potential CD, i.e. TGA-positive children having a normal mucosa and following gluten contain diet (potential CD); and eight TGA negative children displaying a morphologically normal mucosa (references).
RNA preparation
Cryopreserved biopsies were used for RNA isolation, according to standardized methodology at our laboraory as described previously [6] . Total RNA was isolated from frozen biopsies, DNase treated and quality checked using Agilent 2100 Bioanalyzer (Agilent Technologies) according to the manufacturers´ guidelines, as described before [6] .
Th17 signalling pathway PCR array
For the real-time PCR-array analyses, 1.4μg of total RNA was reversly transcribed into cDNA (15 min at 42°C and 5 min at 95°C), mixed into a PCR-cocktail (together with DNA polymerase, SYBR®Green dye, ROX reference dye and double-distilled H2O) and loaded on the Human Th17 for Autoimmunity & Inflammation RT² Profiler™ PCR Array (PAHS-073, SABiosciences, Frederick, Maryland, USA). Subsequently, PCR amplification was performed (10 min at 95°C, 40 cycles of 15 s at 95°C, 1 min at 60°C), according to the manufacturer´s guidelines, as described earlier [6] .
Only genes with threshold cycle (Ct)-values <35 were considered to be detectable, according to the manufacturer´s guidelines. The Ct-values of the genes were normalized with the average Ct-value of all five housekeeping genes (HKG) on the array: Beta-2-microglobulin (B2M), Hypoxanthine phosphoribosyltransferase 1 (HPRT1), Ribosomal protein L13a (RPL13A), Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and β-actin (ACTB). The ΔCt and the median fold change (2 -MEDIAN ΔΔCt ) were calculated for the genes on the array.
Quantitative RT-PCR
The mucosal expression of IL-17 was undetectable with the PCR-arrays and was therefore analysed with conventional quantitative PCR (qPCR), which is a more sensitive method for IL-17 detection.
For qPCR (qPCR) of IL-17A, total RNA was reversely transcribed into cDNA using TaqMan Reverse Transcription reagents (Applied Biosystems, Foster City, CA). qPCR of IL-17A (cat. no. Hs00174383_m1) was then carried out using TaqMan Gene Expression Assay (Applied Biosystems), as described earlier [9] . 18s rRNA was used as endogenous control (Hs99999901_s1) and an exogenous cDNA pool calibrator as an interassay standard to which normalized samples were compared. The relative expression level of IL-17A was quantified using the comparative Ct method, where 2 -Ct represents the relative amount of the gene of interest in the sample, according to the manufacturer´s guidelines, as described earlier [9] . For presentations the relative amounts (2 -Ct ) of IL-17 was multiplied by a factor 1000 and expressed as relative units. To enable statistical analyses if the Ct value not reached a quantitative level, an artificial value corresponding to half of the lowest quantitative value in relative units was given to the sample.
Statistical analysis
The data analysis was performed with SPAW Statistics 17.0 for Windows (SPSS Inc., Chigaco, IL, USA) and GraphPad prism software (San Diego, CA). Mann-Whitney U test was used for comparisons between the groups and p-values <0.05 were considered as statistically significant.
For the PCR-arrays a cut off criterion for the gene expression fold change (2 -MEDIAN ΔΔCt ) between the samples was used. A fold change of 1.4 was considered to be an enhancement, whereas a fold change of -1.4 was considered to be a reduction of the studied genes. The difference in the gene expression between the groups was considered significant if it fulfilled the following two criteria: a fold change of (±1.4) together with a p-value of <0.05 between the groups, as described before [6] .
The statistical analyses were not corrected for multiple comparisons.
The expression profiles of genes passing the double cut-off criterion were visualised with Self
Organizing Map (SOM)-clusters formed by GeneCluster 2.0 (Whitehead Institute, Center for Genome Research, Massachusetts Institute of Technology, Cambridge, MA), using Tamayo´s algorithm [10] . The expression data was pre-processed by normalization (mean: 0, variance: 1)
before it was clustered according to Tamayo et al [10] as described before [6] .
In order to disclose multivariate responses Principal Component Analysis (PCA) of the HKGnormalised Real time-PCR-array data was employed, using GeneEx (MultiD Analyses/TATAA Biocenter, Gothenburg, Sweden). The data was pre-processed by calculating the relative expression of the genes, log2-transformation and mean-centering. Genes passing the double cut-off criteria; the fold change cut-off (±1.4) together with a significant difference in gene expression between the study groups (Mann-Whitney U test (p<0.05) between children with untreated-CD and/or GFDtreated-CD and/or children without CD (references + potential CD) were visualised with PCA.
Ethical Considerations
The study was approved by the Regional Ethics Committee for Human Research at the University Hospital of Linköping, Sweden, and written informed consent was obtained from parents and the children who were old enough to agree to participation.
Results
Detectable PCR-array products (<35 cycles) were obtained from the majority (n=72) of the 84 genes associated with the Th17 signalling pathway (Supplementary Table 1 ). The expression of 61 genes in total differed (with a fold change value higher than ±1.4) among the groups of children studied ( Figure 1 ). The expression level; -Ct-value, of 23 genes was statistically different between the groups (Supplementary Table 2 ). The Ct-values of IL-17A in the samples were all below 35 cycles, which is the cut off level for detection in the PCR arrays. The expression of IL-17A was analyzed with conventional qPCR, due to its higher sensitivity [9] . The IL-17A levels of the samples analyzed with qPCR displayed moderate mRNA expression (median Ct-value: 31.6; range
28.1-40 cycles).
Cluster analysis
Unsupervised cluster analysis (SOM-clustering) of the 23 genes passing the double cut-off criterion displayed 4 distinct clusters; C0-C3, including 5, 3, 5 and 10 genes respectively ( Figure 2 ).
Mucosal gene expression in potential CD
Children with potential CD had elevated CD8A gene expression level, but reduced IL-21, FOXP3, CSF2, TRAF6, MMP9 and CLEC7A expression when compared to the references ( Table 2) . Interestingly, the qPCR analyses of IL-17 showed that children with potential CD expressed lower levels of IL-17A than the reference children, but also compared to children with untreated and GFD-treated CD ( Figure 3 ). 
Mucosal gene expression in untreated and GFD-treated CD
Discussion
During recent years the role of IL-17 immunity in CD has received a lot of interest due to the key function of Th17 immunity in mucosal defence. Here, we used real-time PCR arrays, an applicable tool for gene expression studies [11] [6] to analyse the mucosal immune activation stage of a broad range of Th17 related genes in small intestinal biopsies from children at different stages of CD i.e.
untreated, potential and GFD-treated CD.
We found that children with untreated CD and villous atrophy expressed elevated levels of IFN-, IL-17A, MMP3 and CD8A but diminished levels of IL-17RE, RORc, NFATC2, CCL22, CD4, CD247, IL-18 and STAT6 as compared to the reference children. The elevated expression of CD8A
was observed in all stages of CD; i.e. in potential, untreated and GFD-treated CD. This indicates that activation of the cytotoxic T-cells (Tc) is a basic feature in CD related mucosal inflammation and not only triggered by gliadin because it is still seen after one year on GFD. As expected, high levels of mucosal IFN- expression were seen in children with GFD-treated CD when compared to the references indicating that the dysregulated IFN- response is not normalized by a strict GFDtreatment for one year. Thus, elevated mucosal IFN- and CD8A in patients on GFD suggests that Th1 activation is the underlying mucosal immune aberrancy in CD and not totally down-regulated by dietary treatment. These results also suggest that in the etio-pathogenesis of CD an unknown factor which not is gliadin is playing a role. The dysregulated Th2 response in untreated CD, characterised by reduced CCL22, IL-18 and STAT6 levels, is likely a reflection of the increased Th1 response since these changes were normalized by the GFD-treatment. This is in agreement with previous studies [6, 12] .
Our results also show that the mucosal IL-17A response was elevated at the late stage of CD when villous atrophy has developed. Mucosal IL-17A displayed elevated expression in children with untreated CD when compared to GFD treated children and also when compared to children with potential CD. This is in agreement with previous studies [8, 9, 12, 13] . In contrast to the elevated IL-17A level in untreated CD, the expression of RORc, IL-17RE and IL-23R was diminished. regulation in mucosa is actually related to the mechanisms of protection [8] . In a previous study we showed that IL-17 induced anti-apoptotic rather than apoptotic responses in an epithelial cell line [9] . IL-17 in mucosal anti-microbial defence has been shown to contribute to the gut barrier function and up-regulation of IL-17 diminishes the dissemination of pathogens from the intestinal lumen [15] . Furthermore, the small intestinum seems to be responsible for the control of the response by eliminating Th17 cells and by induction of a phenotype change in Th17 cells, which acquire suppressive phenotype characteristics and participate in the regulation of immune responses in small intestine [16] . The reduced expression of CD247, CD4, and NFATC2 which was seen in CD children with villous atrophy may indicate that the T-cell activation and signalling is disturbed in untreated CD. CD247
is an amplification module in the TCR/CD3 signalling cascade, but also a master regulator and sensor of innate and adaptive immune responses. A defective expression/function of CD247 was suggested to be associated with pro-inflammatory conditions, autoimmune diseases and refractory CD [36] [37] [38] [39] [40] . Cells expressing low levels of CD247 produce IFN- but they do also possess enhanced migratory capacity and the ability to enrich in inflamed tissues [37] . It is however unknown if the down-regulation of CD247, which often occur concurrently with Th1 responses, is induced by or a consequence of the inflammatory response. Down-regulation of CD247 most likely represents a beneficial mechanism attenuating hyper-activated immune responses in acute inflammatory conditions [41] . NFATC2 is a multi-faceted activation marker, important for cytokine production by peripheral T-cells, which also has been suggested to regulate mucosal T-cell activity and to be important in innate mucosal immune responses [42] . Treatment with a GFD seems to normalise the defective T-cell activation and signalling, since the expression of the aforementioned genes were similar in GFD-treated CD and references. Thus, the diminished expression of these genes involved in T-cell signalling and activation most likely represents a normal mechanism by which the immune system regains homeostasis/balance during inflammatory conditions.
Multivariate data analysis techniques such as PCA and cluster analysis are nowadays more common used for analysis and visualization of expression data. Here, four distinct clusters were formed when SOM-clustering was used to display the expression pattern of the 23 differentially expressed genes in children at different stages of CD. In our study, the PCA separated the groups of children with untreated CD from children with GFD-treated CD, potential CD and reference children without CD. and reference children without CD (green).
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